Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • InderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Bolag under bevakning
    • Teamet

Du verkar använda en bredare skärm. Vill du aktivera en bredare visningsupplevelse på denna sida?

OrderYOYO – Presentation of Q3 2023 trading update

Av HC Andersen Capital
OrderYOYO

In OrderYOYO's Q3 2023 results, OrderYOYO continued this year's strong momentum with 38% and 31% ARR growth and revenue growth, respectively. The momentum was further highlighted by the fourth upward revision of 2023 guidance this year on both the top line and bottom line. 

In addition to continued strong revenue growth, earnings focus continues, with an EBITDA result of DKK 16m in the first nine months of the year, an improvement of DKK 20m vs 2022. Q3 also was the first full quarter with positive cash EBITDA, and thus growth momentum is fully funded by operations.  In the report, they also released guidance for 2024, where they expect to continue double-digit growth on both topline and EBITDA.

The results, how this is achieved in challenging market conditions, and what's behind the guidance for the rest of 2023 and 2024 were some of the subjects we touched upon in this event, where we were joined by CEO Jesper Johansen, CFO Jesper Hyveled, and deputy CEO Matthias Thom.

OrderYOYO is a Danish Software-as-a-Service (SaaS) company that provides takeaway restaurants with all the necessary software to serve their customers, including online ordering, payment, marketing and business management solutions. The software enables restaurants, primarily within takeaway, to have their own-branded online presence direct to consumers instead of via food portals.

Disclaimer: HC Andersen Capital receives payment from OrderYOYO for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis 11.28, 19 October 2023.

Recent videos

Investing in the life science sector
LIVE
2025-12-18 07:47
Life Science Companies as Investments | Life Science Night Dec. 9, 2025
2025-12-16 08:30 Aiforia Technologies
Truecaller, Webcast, Press Conference, 2025
2025-12-15 13:00 Truecaller
Herantis Pharma as an Investment | Life Science Night Dec 9, 2025
2025-12-15 13:00 Herantis Pharma
Orion as an Investment | Life Science Night Dec. 9, 2025
2025-12-13 12:50 Orion
Titta på alla videos
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.